CollPlant Biotechnologies (CLGN) Projected to Post Earnings on Wednesday

CollPlant Biotechnologies (NASDAQ:CLGN) is anticipated to post its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect CollPlant Biotechnologies to post earnings of ($0.42) per share and revenue of $0.36 million for the quarter.

CollPlant Biotechnologies Trading Up 0.8 %

Shares of NASDAQ CLGN traded up $0.03 during trading on Thursday, reaching $3.12. 602 shares of the company traded hands, compared to its average volume of 10,018. The stock has a market cap of $35.68 million, a P/E ratio of -2.02 and a beta of 1.07. The firm’s fifty day simple moving average is $3.61 and its 200 day simple moving average is $4.04. CollPlant Biotechnologies has a 12-month low of $3.00 and a 12-month high of $6.75.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on CLGN. HC Wainwright reiterated a “buy” rating and set a $11.00 price target on shares of CollPlant Biotechnologies in a research report on Friday, November 29th. D. Boral Capital reiterated a “buy” rating and issued a $14.00 target price on shares of CollPlant Biotechnologies in a research note on Wednesday, February 12th.

CollPlant Biotechnologies Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.